Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
40.89
+1.82 (4.66%)
Dec 20, 2024, 4:00 PM EST - Market closed
Veracyte Market Cap
Veracyte has a market cap or net worth of $3.17 billion as of December 20, 2024. Its market cap has increased by 73.40% in one year.
Market Cap
3.17B
Enterprise Value
2.91B
1-Year Change
73.40%
Ranking
Category
Stock Price
$40.89
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $3.17B, an increase of 1,056.13%. That is a compound annual growth rate of 24.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.17B | 57.72% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovoCure | 3.30B |
| MoonLake Immunotherapeutics | 3.27B |
| Inari Medical | 3.21B |
| Denali Therapeutics | 3.10B |
| Envista Holdings | 3.10B |
| Janux Therapeutics | 3.02B |
| Xenon Pharmaceuticals | 2.99B |
| BrightSpring Health Services | 2.96B |